Finance

Beta
Lists
AVBP:NASDAQ
Arrivent Biopharma Inc
၃၃.၂၈ US$
-၁.၁၅%
(-၀.၃၉) 1D
ဇူ ၁၀, GMT-၄ ၀၉:၄၆:၄၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVBP...
Open
၃၃.၆၅ US$
High
၃၄.၀၀ US$
Low
၃၂.၉၇ US$
Mkt. cap
၁၅၈.၈၆ ဋေ
Avg. vol.
၆.၇၇ သိန်း
Volume
၄.၈၈ ထောင်
52-wk high
၃၅.၈၃ US$
52-wk low
၁၆.၁၀ US$
EPS
-၃.၅၂ US$
Shares outstanding
၄.၆၆ ကုဋေ
No. of employees
၇၇
Open
၃၃.၆၅ US$
High
၃၄.၀၀ US$
Low
၃၂.၉၇ US$
Mkt. cap
၁၅၈.၈၆ ဋေ
Avg. vol.
၆.၇၇ သိန်း
Volume
၄.၈၈ ထောင်
52-wk high
၃၅.၈၃ US$
52-wk low
၁၆.၁၀ US$
EPS
-၃.၅၂ US$
Shares outstanding
၄.၆၆ ကုဋေ
No. of employees
၇၇
News stories
From sources across the web
Stock Titan
Stock Titan
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
AI imaging tie-up could bring Jiuzi about $1M in profit
PR Newswire
PR Newswire
·
ပြီးခဲ့သည့် ၄၄ မိနစ်
NYSE Content Update: Samos Energy Acquisition to Make NYSE Debut
CNBC
CNBC
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
Opening Bell: July 10, 2026
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Nasdaq's hottest winners just fell behind: Chart of the Day
About Arrivent Biopharma Inc
CEO-
Employees၇၇
Founded၂၀၂၁
HeadquartersNewtown Square, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitearrivent.com
Analyst ratings
Based on 9 analysts giving stock ratings to AVBP in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for AVBP in the last 3 months.
Highest
Current ၃၃.၂၈ US$
၅၀.၀၀ US$ (+၅၀.၂၃%)
Average
၄၃.၀၈ US$ (+၂၉.၄၄%)
Lowest
၃၁.၇၄ US$ (-၄.၆၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boris Peaker
JonesTrading
Buy
Maintained
၄၅.၀၀ US$
+၃၅.၂%
07/06/2026
Supawat Thongthip
Truist Financial
Buy
Reiterated
၃၁.၇၄ US$
-၄.၆%
06/22/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
၃၁.၇၄ US$
-၄.၆%
06/22/2026
Yigal Nochomovitz
Citi
Buy
Maintained
၄၃.၀၀ US$
+၂၉.၂%
06/03/2026
Michael Schmidt
Guggenheim
Buy
Maintained
၄၅.၀၀ US$
+၃၅.၂%
06/01/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
၅၀.၀၀ US$
+၅၀.၂%
06/01/2026
Jeet Mukherjee
BTIG
Buy
Maintained
၄၂.၀၀ US$
+၂၆.၂%
05/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
၄၅.၀၀ US$
+၃၅.၂%
05/29/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
၄၂.၀၀ US$
+၂၆.၂%
05/16/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၄၄.၀၀ US$
+၃၂.၂%
05/12/2026
Soumit Roy
JonesTrading
Buy
Maintained
၄၅.၀၀ US$
+၃၅.၂%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၂.၇၇ ကုဋေ
၃.၂၂ ကုဋေ
၃.၂၂ ကုဋေ
၃.၇၆ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၉၀ သန်း
၆.၁၅ သန်း
၆.၆၅ သန်း
၈.၄၉ သန်း
Operating expense
၃.၃၆ ကုဋေ
၃.၈၃ ကုဋေ
၃.၈၈ ကုဋေ
၄.၆၁ ကုဋေ
Total operating expenses
၃.၃၆ ကုဋေ
၃.၈၃ ကုဋေ
၃.၈၈ ကုဋေ
၄.၆၁ ကုဋေ
Operating income
-၃.၃၆ ကုဋေ
-၃.၈၃ ကုဋေ
-၃.၈၈ ကုဋေ
-၄.၆၁ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၃.၁၄ ကုဋေ
-၃.၄၈ ကုဋေ
-၃.၆၀ ကုဋေ
-၄.၃၃ ကုဋေ
EBT excluding unusual items
-၃.၁၄ ကုဋေ
-၃.၅၀ ကုဋေ
-၃.၅၅ ကုဋေ
-၄.၃၃ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၃.၁၄ ကုဋေ
-၃.၄၈ ကုဋေ
-၃.၆၀ ကုဋေ
-၄.၃၃ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၉၀
-၀.၈၃
-၀.၇၈
-၀.၉၆
Interest and investment income
၂.၂၂ သန်း
၃.၃၄ သန်း
၃.၂၈ သန်း
၂.၇၉ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၂၂ သန်း
၃.၃၄ သန်း
၃.၂၈ သန်း
၂.၇၉ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer